🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Nasdaq Gains 1%; Intuit Shares Plunge

Published 24/05/2024, 17:07
© Reuters.  Nasdaq Gains 1%; Intuit Shares Plunge

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Friday.

The Dow traded up 0.25% to 39,163.18 while the NASDAQ rose 1.04% to 16,909.33. The S&P 500 also rose, gaining, 0.69% to 5,304.30.

Check This Out: Top 3 Health Care Stocks That May Crash In May

Leading and Lagging Sectors

Communication services shares jumped by 1.1% on Friday.

In trading on Friday, health care shares fell by 0.1%.

Top Headline

Shares of Intuit Inc. (NASDAQ:INTU) fell around 8% on Friday following third-quarter results.

The company posted better-than-expected earnings for its third quarter and boosted its full-year outlook. However, the company issued weak earnings guidance for the current quarter.

Intuit’s third-quarter revenue increased 12% year-over-year to $6.737 billion, beating the consensus estimate of $6.647 billion. The financial technology platform company reported adjusted earnings of $9.88 per share, beating analyst estimates of $9.37 per share, according to Benzinga Pro.

Equities Trading UP

  • Akanda Corp. (NASDAQ:AKAN) shares shot up 70% to $4.0555. The international medical cannabis company implemented a 1-for-40 reverse stock split on its ordinary shares effective May 23, 2024, according to a recent exchange filing.
  • Shares of Merus N.V. (NASDAQ:MRUS) got a boost, surging 37% to $60.37 after the company announced the publication of an abstract regarding petosemtamab in combination with pembrolizumab on the 2024 ASCO Annual Meeting website.
  • Deckers Outdoor Corporation (NYSE:DECK) shares were also up, gaining 13% to $1,018.75 after the company reported better-than-expected quarterly financial results.
Equities Trading DOWN

  • Verastem, Inc. (NASDAQ:VSTM) shares dropped 61% to $4.70. The company announced that it initiated the rolling submission of a NDA to the FDA for accelerated approval of the combination of avutometinib and defactinib for adult patients with recurrent KRAS mutant low-grade serous ovarian cancer.
  • Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI) were down 26% to $7.10. TriSalus Life Sciences announced commencement of exchange offer and consent solicitation relating to warrants.
  • Genelux Corporation (NASDAQ:GNLX) was down, falling 45% to $2.5889 after the company reported pricing of approximately $27.5 million underwritten offering of common stock and accompanying warrants.
Also Check This Out: Wall Street’s Most Accurate Analysts’ Views On 3 Financial Stocks Delivering High-Dividend Yields


In commodity news, oil traded up 0.9% to $77.52 while gold traded up 0.1% at $2,340.40.

Silver traded up 0.7% to $30.665 on Friday, while copper rose 0.1% to $4.7965.

Euro zone

European shares were lower today. The eurozone's STOXX 600 fell 0.30%, Germany's DAX declined 0.30% and France's CAC 40 slipped 0.22%. Spain's IBEX 35 Index fell 0.70%, while London's FTSE 100 declined 0.14%.

Producer prices in Spain declined by 6.6% year-over-year in April compared to an 8.2% fall in March. The manufacturing climate indicator in France declined to a reading of 99 in May. German economy grew by 0.2% quarter-over-quarter in the three months to March versus a 0.5% contraction in the prior period. Retail sales in the UK fell 2.3% month-over-month for April versus a revised 0.2% decline a month ago.

Asia Pacific Markets

Asian markets closed lower on Friday, with Japan's Nikkei falling 1.17%, China's Composite Index declining 0.88%, Hong Kong's Hang Seng Index falling 1.38% and India's S&P BSE Sensex falling 0.1%.

The annual inflation rate in Japan eased to 2.5% in April versus 2.7%, while core consumer price index in Japan increased 2.2% year-over-year in April versus a 2.6% rise in the prior month.


U.S. durable goods orders increased by 0.7% month-over-month in April compared to a revised 0.8% gain in March. However, markets were expecting for a 0.8% decrease.

Now Read This: Apple To Rally Over 47%? Here Are 10 Top Analyst Forecasts For Friday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.